Journo treated with experimental Ebola drug

2014-10-07 22:00

The American video journalist being treated for Ebola in Nebraska is receiving the same experimental drug being used to treat a patient in Dallas.

Nebraska Medical Centre Dr Phil Smith today said that 33-year-old Ashoka Mukpo is receiving brincidofovir, an oral medication developed to fight several other viruses.

Doctors sought federal permission to use the drug for Mukpo. It’s also being used in Dallas to treat Thomas Eric Duncan, the first person diagnosed with Ebola in the US.

The 33-year-old Mukpo was diagnosed in Africa and flown to the Omaha hospital, which houses a specialised isolation unit to treat infectious diseases. His father says Mukpo is, as expected, experiencing some vomiting and diarrhoea.

American aid worker Dr Rick Sacra was also treated for Ebola at the Nebraska hospital.

Join the conversation! encourages commentary submitted via MyNews24. Contributions of 200 words or more will be considered for publication.

We reserve editorial discretion to decide what will be published.
Read our comments policy for guidelines on contributions. publishes all comments posted on articles provided that they adhere to our Comments Policy. Should you wish to report a comment for editorial review, please do so by clicking the 'Report Comment' button to the right of each comment.

Comment on this story
Comments have been closed for this article.

Inside News24

Traffic Alerts
There are new stories on the homepage. Click here to see them.


Create Profile

Creating your profile will enable you to submit photos and stories to get published on News24.

Please provide a username for your profile page:

This username must be unique, cannot be edited and will be used in the URL to your profile page across the entire network.


Location Settings

News24 allows you to edit the display of certain components based on a location. If you wish to personalise the page based on your preferences, please select a location for each component and click "Submit" in order for the changes to take affect.

Facebook Sign-In

Hi News addict,

Join the News24 Community to be involved in breaking the news.

Log in with Facebook to comment and personalise news, weather and listings.